// App-Quantinova.ai

2555 : A phase I study of ARQ 197 in combination with temsirolimus in patients (Pts) with advanced solid tumors.

Researchers

Presenter

  • Amy M. Braden

Principal Investigators

  • Kari Braun Wisinski

  • Daniel Mulkerin

  • Jennifer Heideman

  • Jill Kolesar

  • Glenn Liu

Medical Centers

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • University of Wisconsin Hospital and Clinics, Madison, WIUniversity of Wisconsin, Madison, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cytochrome P450 2C19

Drug/Treatment

  • Temsirolimus

  • ARQ 197

Outcome

  • Positive

Study Design

  • open label

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved